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An Essential Role for a MEK-C/EBP
Pathway during Growth Factor-Regulated
Cortical Neurogenesis
has perhaps been best studied in the developing cortex
(Lillien, 1998; Shen et al., 1998). In vivo, cortical neuro-
genesis occurs during embryogenesis, while gliogen-
esis largely occurs postnatally. Remarkably, this same
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Results 90% of control, GFP-positive cells expressed detectable
phosphoERK, while only 14% of DN-MEK-positive cells
MEK Activity Is Important for Cortical did so.
Neurogenesis Having confirmed that the DN-MEK adenovirus inhib-
To address the signaling mechanisms underlying corti- ited ERK activation, we then asked whether this affected
cal neurogenesis, we examined progenitors isolated cell survival. Cells were infected with 50 MOI of DN-MEK
from E12-E13 mouse cortex and plated in FGF2 (Toma or GFP adenoviruses, were cultured for 3 or 5 days in
et al., 2000; Slack et al., 1998; Gloster et al., 1999); these FGF2, and then analyzed for apoptosis. Double-label
cells are dividing, nestin-positive progenitors, many of analysis for the viral gene product and for TUNEL (Figure
which exit the cell cycle and express the panneuronal 1E) revealed a low level of apoptosis in control or GFP-
markers III-tubulin, neuron-specific enolase (NSE), infected cells, and showed that this was not affected
MAP-2, neurofilament-M, and NeuN, as well as a neuron- by DN-MEK expression at 3 or 5 days. We then asked
specific T1 -tubulin promoter linked to a nuclear whether the MEK pathway was important for neurogen-
-galactosidase reporter gene (Gloster et al., 1994, esis. Cells were infected with 50 MOI of DN-MEK adeno-
1999). virus and were cultured for 3 days in FGF2 or for 5 days
We first confirmed, as previously documented (Wil- in FGF2 plus 50 ng/ml PDGF. As controls, sister cultures
liams et al., 1997; Bonni et al., 1997; Park et al., 1999), were infected with 50 MOI of adenoviruses expressing
that PDGF enhanced neurogenesis and CNTF enhanced either GFP or the wild-type MEK protein. Double-label
gliogenesis in these cultures. Progenitors were cultured immunocytochemistry revealed that DN-MEK, but not
from E13 line K6 T1:nlacZ transgenic mouse embryos wild-type MEK or GFP, inhibited induction of both the
(Gloster et al., 1994); this transgene is induced in virtually T1:nlacZ transgene and NSE (Figure 1F and 1G). Similar
all postmitotic cortical neurons (Gloster et al., 1999). results were obtained in the presence of FGF2 plus
Cells were then treated for 5 days with FGF2 plus or PDGF (Figure 1H). These results were not due to adeno-
minus 50 ng/ml PDGF and immunostained for NSE or viral infection, since similar results were obtained when
for the -galactosidase gene product of T1:nlacZ (Fig- progenitors were transfected with the same HA-tagged
ure 1A). This analysis revealed that relative to FGF2 DN-MEK construct; approximately 40% of GFP-express-
alone, FGF2 plus PDGF treatment enhanced the number ing cells coexpressed the neuron-specific marker NeuN
of cells expressing NSE or T1:nlacZ by approximately at 3 days, while only approximately 25% of DN-MEK-
2.0-fold (p  0.05 in two independent experiments). We expressing cells did so (p  0.05). Thus, MEK activity
then confirmed that CNTF promoted gliogenesis by is essential for neurogenesis in the presence of FGF2
treating cultures with FGF2 plus 50 ng/ml CNTF for 5 with or without PDGF.
days and then immunostaining for the astrocyte-specific
glial fibrillary acidic protein (GFAP). GFAP was not ex- The C/EBP Transcription Factor Family Is
pressed in progenitors cultured in FGF2 alone over this Essential for Cortical Neurogenesis
timeframe, while FGF2 plus CNTF caused 8%–25% of The C/EBP family is known to regulate cellular differenti-
the cells to express GFAP in four independent experi- ation downstream of MEK in nonneural cells (Davis,
ments (Figure 1B).
1995). To determine a potential role for C/EBPs during
One pathway activated by the PDGF and FGF recep-
neurogenesis, we first asked whether they were ex-
tors and implicated in cellular differentiation is the MEK-
pressed in cortical progenitors. RT-PCR analysis dem-ERK pathway (Davis, 1995). To examine a potential role
onstrated that cortical progenitors expressed C/EBPsfor this pathway in neurogenesis, we first examined it
, , and  (Figure 2A). We then asked whether C/EBPsbiochemically, performing Western blots for phosphory-
had any role in cortical neurogenesis, taking advantagelated, activated ERKs, direct downstream substrates
of a recombinant adenovirus expressing an acidic formof MEK. PhosphoERK was detectable in progenitors
of C/EBP (A-C/EBP) that strongly and selectively bindscultured in FGF2, and addition of 50 ng/ml PDGF for 10
to all C/EBP family members and inhibits their bindingmin caused an increase in phosphoERK (Figure 1C). We
to DNA (Greenwel et al., 2000; Krylov et al., 1997). Tothen utilized a recombinant adenovirus expressing an
confirm the specificity of this A-C/EBP protein for mem-HA-tagged, dominant-inhibitory form of MEK (DN-MEK)
bers of the C/EBP family, and not for other leucine-(U. Zirrgeibel et al., submitted) to ask whether MEK-ERK
zipper transcription factors, gel shift assays were per-pathway activation was important for neurogenesis. We
formed. Incubation of a molar equivalent of purified A-C/have previously used recombinant adenovirus to manip-
EBP with C/EBP completely inhibited the ability ofulate both cortical progenitor cells and neurons (Slack
C/EBP homodimers to bind and shift a radiolabeledet al., 1998, 1996; Toma et al., 2000; Wartiovaara et al.,
double-stranded DNA containing the cognate DNA bind-2002), and have demonstrated that these vectors do not
ing site (Figure 2C). In contrast, even a 100-fold excesshave any effect on neurogenesis or on cell survival under
of A-C/EBP had no effect on the binding of CREB, vitello-conditions used here.
genin binding protein (VBP), or a fos/junD heterodimerAs a prelude to biological experiments, we confirmed
to their cognate binding sites (Figure 2C).by Western blot analysis that a DN-MEK protein of the
We then used A-C/EBP to ask whether C/EBPs wereappropriate size was expressed in infected progenitors
essential for cortical neurogenesis; progenitors were(Figure 1D). We then confirmed that MEK activity was
isolated from T1:nlacZ mice, and infected with 50 MOIinhibited; cells were infected upon plating with 50 MOI of
of adenoviruses expressing flag-tagged A-C/EBP orDN-MEK or GFP adenoviruses, and maintained 3 days in
GFP. Western blot analysis confirmed that the infectedFGF2. Double-label immunocytochemistry for phos-
phoERK and for the HA-tag in DN-MEK revealed that cells expressed A-C/EBP (Figure 2B). We then measured
MEK and C/EBPs Promote Neurogenesis
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Figure 1. The MEK Pathway Is Important for the Generation of Neurons from Cortical Progenitor Cells
(A) Immunostaining for NSE (top two panels) and for the -galactosidase product of T1:nlacZ (bottom two panels) in progenitors maintained
in FGF2 and PDGF for 5 days. Each pair of panels represents the same field, with the left panel being the immunostaining and the right panel
the Hoechst labeling to show all of the nuclei in the field.
(B) Immunostaining for GFAP in progenitors maintained for 5 days in FGF2 with (two left panels) or without (two right panels) 50 ng/ml CNTF.
(C) Western blot analysis for the phosphorylated, activated form of ERK (pERK) in progenitors maintained in FGF2 alone or stimulated for 10
min with 50 ng/ml PDGF. The bottom panel is a reprobe for total ERK-1 protein.
(D) Western blot analysis for the HA-tag in the DN-MEK protein, showing expression of a protein of the appropriate size in progenitors and
293 cells.
(E) Quantitation of the number of cells expressing either GFP or the HA-tag in the DN-MEK protein that were TUNEL positive at 3 and 5 days
following adenovirus infection. Each pair of bars represents one experiment. No significant difference was observed between GFP- versus
DN-MEK-positive cells (p  0.05).
(F) Double-label immunocytochemistry for the HA-tag in DN-MEK and for NSE (top three panels) or the T1:nlacZ gene product (bottom three
panels) in progenitors infected with the DN-MEK adenovirus for 3 days. In both cases, the left panels show HA-positive cells (DN MEK), the
middle the neuron-specific marker (NSE or T1:nlacZ), and the right the Hoechst staining for the same field. Arrows indicate cells positive for
DN-MEK, but not for neuronal proteins.
(G and H) Quantitation of data similar to that shown in (F), for cells infected with adenoviruses expressing DN-MEK, wild-type MEK (WT-MEK),
or GFP and grown in FGF2 for 3 days (G) or FGF2 plus 50 ng/ml PDGF for 5 days (H). Each pair of bars derives from an independent experiment.
*p  0.05 ; **p  0.005.
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Figure 2. Transcriptional Induction of the Ta1 -Tubulin Promoter Is Inhibited in Cortical Progenitors Expressing A-C/EBP, which Inhibits
trans-Activation via All C/EBP Family Members
(A) RT-PCR analysis of C/EBP family members , , and  in cortical progenitor cells. As a control, cells were also analyzed for -actin mRNA.
Std is the molecular weight standard, lane 1 is mouse genomic DNA as a positive control (the primers are located within the same exon), lane
2 is water, lanes 3 and 5 are progenitor cell RNA with no RT, and lanes 4 and 6 are two different preparations of progenitor cell mRNA.
(B) Western blot analysis for the flag-tagged (-Flag) A-C/EBP protein in lysates of infected progenitors or 293 cells.
(C) Specificity of A-C/EBP for C/EBPs and not other leucine-zipper transcription factors. The purified transcription factors (B-ZIPs) C/EBP,
CREB, VBP, and the fos/junD heterodimer were mixed with purified A-C/EBP at concentrations ranging from equimolar to a 100-fold molar
excess, prior to incubation with a labeled, double-stranded oligonucleotide encoding their cognate DNA binding sequence (denoted in the
figure).
(D) Quantitation of TUNEL-positive cells expressing either flag-tagged A-C/EBP or GFP at 3 or 5 days (DIV) following adenoviral infection.
Results are the mean 	 SE of five (3 DIV) or four (5 DIV) individual experiments.
(E) Double-label immunocytochemistry of progenitors for adenovirally driven expression of flag-tagged A-C/EBP (aC/EBP) or GFP (both in
green) and the nuclear -galactosidase reporter gene (in red) driven from the T1:nlacZ transgene. Right panels are Hoechst staining for the
same fields. Note that many GFP-positive but not A-C/EBP-positive cells express the transgene (arrows).
(F and G) Quantitation of data similar to that shown in (E) in progenitors infected with A-C/EBP (Ad-aC/EBP) or GFP (Ad-GFP) adenoviruses
for 3 (F) or 6 days (G), and then analyzed for expression of T1:nlacZ. In total, 14 individual experiments gave similar results. Results indicate
mean 	 SE. *p  0.05, **p  0.005.
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cell survival at 3 and 5 days following infection. Double- volved in this pathway is Rsk, which is activated by
MEK/ERK and which directly phosphorylates mouselabel analysis for the viral gene product and TUNEL
(Figure 2D) revealed that A-C/EBP expression had no C/EBP on Thr217 (Buck et al., 1999). To determine
whether Rsk might be one way that MEK “talks to” theeffect on survival relative to controls. Moreover, approxi-
mately the same number of cells were A-C/EBP positive C/EBPs, we performed Western blots for phosphory-
lated Rsk1. This analysis revealed that progenitors ex-at 3 and 6 days postinfection (approximately 20%), indi-
cating that A-C/EBP expressing cells did not die during pressed Rsk1 and that it was activated by FGF2 (Figure
3F). To test the hypothesis that MEK might promotethis time period. Finally, Hoechst staining of similar cul-
tures at 6 days postinfection demonstrated that approxi- neurogenesis via an Rsk1-C/EBP pathway, we then uti-
lized a C/EBP mutant in which Thr217 was replacedmately 8% and 11% of GFP- versus A-C/EBP-infected
cells displayed the fragmented nuclear morphology typi- by glutamate (Glu-217), thereby acting as a phosphory-
lation mimic at the Rsk site.cal of apoptosis, a difference that was not statistically
significant (p 
 0.171, results from four experiments). For these experiments, we first showed that progeni-
tors were reliably cotransfected using independent plas-Thus, inhibition of the C/EBPs had no effect on cell
survival at any time point during these experiments. mids expressing GFP and red fluorescent protein (RFP)
(data not shown). We then cotransfected progenitorWe next asked whether C/EBPs were essential for
progenitors to transcribe the neuronal T1-tubulin pro- cells shortly after plating with the C/EBP Glu-217 mu-
tant and GFP, or, as controls, with wild-type C/EBPmoter. Double-label immunocytochemistry of cells in-
fected for 3 days with A-C/EBP or GFP adenoviruses and GFP or GFP alone. Two days later, we performed
immunocytochemistry for NSE, NeuN, or III-tubulin.revealed that only 3%–14% of A-CEBP-infected cells
expressed -galactosidase from the T1:nlacZ pro- This analysis (Figure 3G) revealed that approximately
30%–40% of cells transfected with either GFP or wild-moter, relative to 33%–68% of the control, GFP-positive
cells (Figures 2E and 2F). To determine whether A-C/ type C/EBP expressed one of these neuronal genes,
while 50%–60% of cells expressing the C/EBP Glu-EBP was inhibiting as opposed to delaying induction of
the transgene, we performed similar experiments at 6 217 mutant were positive for neuronal markers (Figure
3H). Thus, overexpression of a C/EBP mutant that isdays postinfection. Even at this later time point, only
8%–16% of A-C/EBP-positive cells expressed the trans- a phosphorylation mimic at the Rsk site, but not C/EBP
alone, enhances neurogenesis.gene versus 78%–100% of GFP-positive cells (Fig-
ure 2G).
To determine whether the C/EBPs might play a more The C/EBP Family Robustly trans-Activates
the T1 -Tubulin Promoter by Binding to Sitesgeneral role in regulating induction of the neuronal phe-
notype, we performed similar experiments examining Conserved in the Fish 1-Tubulin Gene
Data presented here indicate that phosphorylation ofNSE. Immunocytochemistry of cells cultured with FGF2
for 3 days revealed that 60% or more of the cells trans- the C/EBPs in response to activation of the MEK path-
way leads to transcription of neuron-specific genes, andduced with GFP or -galactosidase adenoviruses ex-
pressed NSE, while only 0%–7% of cells expressing hence, induction of a neuronal phenotype. As one poten-
tial direct transcriptional target of the C/EBPs, we fo-A-C/EBP did so (Figure 3A). A similar decrease was
observed in cells cultured for 3 days in FGF2 plus PDGF cused upon the promoter for the T1 -tubulin gene;
both the endogenous T1-tubulin gene and its isolated(Figure 3B). Experiments performed at a later time point
with FGF2 plus PDGF confirmed that, as seen with promoter are induced as soon as cortical progenitors
become postmitotic neurons (Miller et al., 1987; GlosterT1:nlacZ, this inhibition of NSE expression persisted
for at least 5 days (Figure 3C). et al., 1994, 1999), and we show here that transcription
of this promoter in transgenic cells is inhibited by A-C/To confirm the specificity of these findings, we trans-
fected progenitors with a construct encoding C/EBP EBP (Figures 2F and 2G). To define sequences within
the T1 promoter that might represent functional C/EBPlacking the trans-activation domain; this truncated pro-
tein binds to C/EBP family members and inhibits tran- binding sites important for neuronal gene expression,
we compared it to the goldfish 1-tubulin gene that, likescriptional activation (Baer and Johnson, 2000). We first
ensured that we could transfect cycling progenitors; the rodent promoter, is neuron-specific and reinduced
during neuronal regeneration (Hieber et al., 1998). Thisimmunocytochemical analysis for Ki67, a protein ex-
pressed in dividing cells, revealed that approximately comparison revealed three sequence motifs of 6–11 nu-
cleotides that were almost identical in sequence in the70% of cells transfected with a GFP expression con-
struct were actively dividing (Figure 3D). We then trans- two promoters, and that were in similar locations within
the first 200 nucleotides (Figure 4A). Two of thesefected progenitors with DN-C/EBP; double-label analy-
sis at 3 days showed that DN-C/EBP significantly motifs, those located at 71 and 120, are at the core
of putative C/EBP family binding sites (Figure 4A).inhibited the induction of NSE relative to GFP-trans-
fected cells (Figure 3E). Thus, C/EBP transcriptional ac- To ask whether these conserved elements were func-
tional C/EBP sites, we performed heterologous cotrans-tivity is essential for induction of neuronal gene expres-
sion as progenitors become neurons. fection experiments. Initially, we utilized a minimal 176
nucleotide T1 -tubulin promoter that contains all three
conserved sites (Figure 4A) and that is sufficient to targetPhosphorylation of C/EBP on the Rsk Site
neuronal gene expression in transgenic mice (P.H., A.S.,Promotes Neurogenesis
A.P., and F.D.M., unpublished data). Expression plas-Activation of MEK leads to phosphorylation of C/EBPs
mids encoding C/EBP , , or  were cotransfectedand enhanced transcriptional activity. One kinase in-
Neuron
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Figure 3. Inhibition of the C/EBP Family Prevents Cortical Progenitors from Becoming Neurons, while a C/EBP Mutant that Is a Phosphorylation
Mimic at the Rsk Site Promotes Neurogenesis
(A) Quantitation of double-label immunocytochemistry of progenitors infected with A-C/EBP (Ad-aC/EBP), GFP (Ad-GFP), or -galactosidase
(Ad--Gal) adenoviruses and analyzed for NSE. 11 individual experiments gave similar results. Results represent mean 	 SE. **p  0.005.
(B and C) Quantitative double-label analysis similar to that shown in (A), except that the cells were cultured for 3 (B) or 5 days (C) in the
presence of FGF2 plus PDGF.
(D) Quantitation of the number of GFP-positive cells expressing Ki67 1 day following transfection. Results derive from three experiments.
(E) Quantitation of immunocytochemistry of progenitors transfected with DN-C/EBP (pDN-C/EBP) or GFP (pGFP) expression plasmids and
then analyzed for expression of NSE. **p  0.005.
(F) Western blot analysis for the phosphorylated, activated form of Rsk (pRsk) or total Rsk (anti-Rsk) in progenitors cultured 1 day in FGF2.
(G) Immunocytochemical analysis for neuron-specific III-tubulin in cells cotransfected with the C/EBP Glu-217 mutant (CA-C/EBP) and GFP.
The right panel is Hoechst staining of the same field, and the arrow indicates a double-labeled neuron.
(H) Quantitation of data similar to that shown in (G); progenitors were cotransfected for 2 days with the C/EBP Glu-217 mutant plus GFP
(pCA-C/EBP), wild-type C/EBP plus GFP (pWT-C/EBP), or GFP alone (pGFP). For III-tubulin, results from three experiments were combined,
while each set of bars for NeuN and NSE derive from independent experiments.
MEK and C/EBPs Promote Neurogenesis
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Figure 4. The C/EBP Family trans-Activates the T1 -Tubulin Promoter, as Determined Using Heterologous Cotransfections
(A) Sequence of a minimal 176 nucleotide T1 -tubulin promoter showing sequence motifs conserved in sequence and location in the goldfish
1-tubulin promoter (bold letters), the putative C/EBP binding sites (circles), and the oligonucleotides used for the gel shift assays (boxes,
denoted A Site, B Site, and C Site). The underlined sequence is the TATAA box.
(B) Relative activation of the T1 -tubulin minimal promoter, determined in NIH 3T3 cells by cotransfecting the reporter plasmid T1 minimal
promoter:CAT with saturating amounts of expression plasmids encoding C/EBP , , or . Fold activation indicates the relative level of
acetylated chloramphenicol produced when the reporter plasmid was cotransfected with the C/EBP-expressing plasmid versus the empty
expression vector. Values were determined from saturation curves using varying amounts of expression construct with a fixed amount of
reporter plasmid. In all cases, the values are those obtained using the same amount (4 g) of reporter plasmid.
(C) Representative CAT assay of NIH 3T3 and PC12 cells cotransfected with C/EBP, and either the 1.1 kb (full-length) or 176-nucleotide
(minimal promoter) reporter constructs.
(D) Cotransfection assays to map the sites necessary for C/EBP-mediated trans-activation of the minimal T1 promoter. Relative transcriptional
activation indicates the level of -galactosidase activity detected in NIH 3T3 cells cotransfected with plasmids expressing the same nlacZ
reporter gene from various T1 promoter deletion constructs with or without the C/EBP expression plasmid. Results indicate the mean 	
SEM from four separate experiments. Full-length T1 indicates the 1.1 kb promoter, minimal T1 promoter indicates the 176 nucleotide
promoter fragment, and 110 and 85 deletion refers to promoter fragments truncated 5 to those nucleotides. *p  0.05; **p  0.005.
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with a reporter construct comprised of this minimal T1 T1 promoter (Figures 5A, 5B, and 5E). Importantly,
promoter linked to chloramphenicol acetyl-transferase complex formation was not inhibited by a similar excess
(CAT). All results were normalized to a cotransfected of a site C oligonucleotide (CMUT) mutated at the core of
CMV-lacZ construct. These experiments revealed that the consensus C/EBP site (Figure 5A). Finally, inclusion
all three C/EBP family members robustly trans-activated of an anti-C/EBP antibody in gel supershift assays led
the minimal T1 promoter (Figure 4B). Saturation experi- to the appearance of a larger molecular weight complex
ments with a fixed amount of T1 reporter construct and (Figures 5A, 5B, and 5E), confirming that the complexes
varying amounts of the C/EBP expression constructs assayed here contained C/EBPs, and demonstrating
revealed that C/EBPs  and  induced 35-fold increases that functional C/EBP is expressed in developing corti-
in CAT activity, while C/EBP  induced an approximately cal progenitors and neurons.
10-fold increase (Figure 4B). To determine whether addi- Oligonucleotides to sites A, B, or C from the T1 pro-
tional C/EBP sites were upstream of 176, we per- moter all formed similar sized complexes when incu-
formed similar studies in NIH 3T3 cells and in the PC12 bated with liver (Figures 5A and 5C), developing brain
neuronal cell line using the previously described 1.1 kb (Figure 5D), or cortical progenitor cell nuclear extracts
T1 promoter (Gloster et al., 1994, 1999). CAT assays (Figure 5E). Complex formation with the three T1 pro-
revealed that both the minimal and 1.1 kb promoters moter oligonucleotides was inhibited by inclusion of an
were trans-activated to a similar degree by C/EBP in excess of either the same oligonucleotide or of the con-
NIH 3T3 cells (Figure 4C). A similar degree of trans- sensus C/EBP site oligonucleotide (Figures 5A–5E). For
activation was observed in PC12 cells (Figure 4C) and the site C oligonucleotide, a site C oligonucleotide mu-
in cos cells (data not shown). tated outside the putative C/EBP binding site inhibited
To more precisely define the C/EBP sites responsible complex formation, while an oligonucleotide mutated
for this robust trans-activation, we generated deletion within the core did not (Figure 5C). For all three oligonu-
mutants of a minimal T1 promoter:nlacZ construct. One cleotides (sites A, B, and C), supershift assays with anti-
construct included sequences to 110, thereby elimi- C/EBP confirmed the presence of C/EBP in the com-
nating the first conserved sequence motif and an addi- plexes (Figures 5C–5E; data not shown).
tional potential C/EBP binding site (A and B sites; see To conclusively demonstrate that sites A, B, and C
Figure 4A). A second construct included sequences to were responsible for the robust trans-activation of the
85, and eliminated the second conserved sequence, T1 promoter by members of the C/EBP family, we mu-
but left intact the third conserved motif (C site; see tated these sites within the context of the minimal pro-
Figure 4A). Cotransfection assays in NIH 3T3 cells re- moter. Specifically, site A was mutated from AGAGATT
vealed that C/EBP led to a robust increase in ACCTCATACCAT to AGAGACCACCTCGTACCAT, site
-galactosidase activity as driven either by the 1.1 kb B from GTCGCTTGCACCAATCACCA to GTCGCCCGC
or 176 nucleotide T1 promoters (Figure 4D). The magni- ACCGATCACCA, and site C from GGGTCTGGACCAA
tude of this increase was similar for both promoter con- CAG to GGGGTCTGGAGGGGCAGGAAAAG. Initially, as
structs but was lower than with the CAT assays, poten- a control, we made oligonucleotides containing the
tially due to differences in stability of the two reporter same mutations, and performed gel shift assays. These
proteins. Deletion of the sequences from 110 to 176 experiments revealed that the C/EBP binding com-
resulted in a consistent decrease in C/EBP-mediated plexes formed with the oligonucleotides for sites A, B,
trans-activation from 10- to 3-fold (Figure 4D). Further or C could not be competed out with the mutated oligo-
deletion of the promoter to 85 had no further effect, nucleotides for those same sites (Figure 6A). We then
indicating (i) that site(s) essential for C/EBP trans-activa- generated the same mutations within the context of the
tion are located between 176 and 110, and down- T1 minimal promoter driving the CAT reporter gene,
stream of 85 (Figure 4A), and (ii) that the conserved and performed CAT assays on NIH 3T3 cells heterolo-
motif between85 and110 is not important for C/EBP
gously cotransfected with C/EBP plus the mutated ver-
trans-activation.
sus wild-type minimal promoter (Figure 6B). All data
To further confirm that the conserved sequence ele-
were normalized to a cotransfected CMV-lacZ con-ments were C/EBP binding sites, we performed gel shift
struct. These assays revealed that, while the mutationsassays. Oligonucleotides were generated to a consen-
had little or no effect on the basal level of transcriptionsus C/EBP site (Williams et al., 1995), as well as to sites
from the minimal promoter, the robust C/EBP-mediatedA, B, and C in the minimal promoter (Figure 4A), and
transcription was greatly decreased (Figure 6B). Thus,were used in gel shifts with liver nuclear extracts, a
these three sites are in fact bona fide C/EBP bindingrich, well-characterized source of C/EBP activity. The
sites, and they are essential for the robust, C/EBP-medi-consensus C/EBP oligonucleotide formed one major
ated transcriptional activation of the T1 promoter.complex when incubated with liver nuclear extract (Fig-
ure 5A). A complex of similar size was observed with
Inhibition of C/EBPs Enhances CNTF-Mediatedextracts from cortical progenitor cells (Figure 5B), from
Gliogenesisembryonic brain (Figure 5E), or from cortical cells iso-
Together, these data support the hypothesis that MEKlated from the telencephalon at time points ranging from
activation leads to Rsk-mediated phosphorylation ofE12 to E18 (data not shown), consistent with the expres-
C/EBPs, and that C/EBPs then promote neurogenesission of C/EBPs in developing cortical progenitors and
from cortical progenitor cells by directly trans-activatingneurons (Figure 2). This complex formation was inhibited
neuronal genes such as T1 -tubulin. To determine theby competition with a 125-fold excess of cold consensus
fate of cortical progenitors expressing A-C/EBP, we firstoligonucleotide, as well as by a similar excess of oligo-
nucleotides corresponding to sites A, B, or C from the asked whether they were subverted to an astrocytic
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Figure 5. Gel Shift Assays for the Three Consensus C/EBP Sites in the T1 Promoter in Nuclear Extracts from Liver, Developing Brain, and
Cortical Progenitor Cells
(A) Liver nuclear extracts were incubated with radiolabeled oligonucleotides corresponding to a consensus C/EBP binding site (TCGACTCCCT
GATTGCGCAATAGGCTCC) (Williams et al., 1995), or the A site from the T1 promoter (see Figure 4A), plus or minus a 125-fold excess of
either the consensus oligonucleotides (con) or of oligonucleotides corresponding to sites A, B, or C from the T1 promoter (see Figure 4A).
As a control, competitions were performed with a C site oligonucleotide mutated within the consensus C/EBP binding motif (Cmut). A major
complex of similar size (open arrow) was formed with both radiolabeled oligonucleotides. The consensus oligonucleotide was also incubated
with anti-C/EBP (Santa Cruz) (lane marked Ab), which induced a supershift to a higher molecular weight (black arrow).
(B) Nuclear extracts from cortical progenitors were incubated with the radiolabeled consensus C/EBP oligonucleotide. Competitions were
performed with a 125-fold excess of oligonucleotides corresponding to the consensus sequence (con) or to site A (A). A larger band appeared
when the complex was incubated with an anti-C/EBP antibody (Ab; open arrow).
(C) Liver nuclear extracts were incubated with radiolabeled oligonucleotides corresponding to the A, B, or C sites from the T1 promoter,
plus or minus a 125-fold excess of either the consensus oligonucleotide (con) or oligonucleotides corresponding to the A, B, or C sites. As
a control, competitions were performed with a C site oligonucleotide mutated within the putative C/EBP binding sequence (Cmut) or outside
this sequence (C). The open arrow indicates the major shifted complex. Oligonucleotides to sites A and B were also incubated with anti-
C/EBP (Ab), which caused a supershift (black arrow).
(D) Nuclear extracts from the E18 brain were incubated with radiolabeled oligonucleotides corresponding to the consensus C/EBP binding
site or the A site from the T1 promoter with or without a 160-fold excess of the same cold oligonucleotides. The major complex is similar
for both oligonucleotides, but an additional complex is formed with the A site oligonucleotide.
(E) Nuclear extracts from cortical progenitor cells (for the Site A oligonucleotide) or from liver (for the consensus oligonucleotide) were incubated
with oligonucleotides corresponding to the consensus sequence or Site A. Competitions were performed with oligonucleotides to the consensus
or to the A site, and supershifts were performed using the antibody to C/EBP (Ab). The black arrow denotes the major complex, while the
open arrow denotes the supershifted complex.
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vealed that, in 5 separate experiments, the large majority
of A-C/EBP-positive cells coexpressed nestin (Figure
7A), while in 11 separate experiments, none of the
A-C/EBP-positive cells expressed GFAP, suggesting
that they remain as undifferentiated progenitor cells.
We then asked whether inhibition of C/EBP affected
the gliogenesis that occurs when CNTF is added to the
cultures in the presence of FGF2. Progenitors were in-
fected with A-C/EBP, -galactosidase, or GFP adenovir-
uses and then exposed to FGF2 plus 50 ng/ml CNTF.
Immunostaining 5 days later revealed that while 10%–
30% of control, GFP- or -galactosidase-expressing
cells coexpressed GFAP, 70%–90% of the A-C/EBP-
positive cells expressed this glial marker (Figure 7C).
Thus, inhibition of C/EBP activity biases cortical progen-
itor cells to become astrocytes in response to CNTF,
suggesting that C/EBP transcriptional activity not only
promotes neurogenesis, but also actively inhibits glio-
genesis in cortical progenitor cells.
Discussion
Data presented here support four major conclusions.
First, these studies demonstrate that the activities of
both MEK and the C/EBP family are necessary for corti-
cal progenitors to become neurons in the presence of
FGF2 and/or PDGF. Second, our data with the C/EBP
Rsk-site phosphorylation mimic suggests that a MEK-
Rsk pathway directly promotes the generation of neu-
rons from cortical progenitors via phosphorylation of
C/EBPs. Third, experiments with the T1 -tubulin pro-
moter indicate that the C/EBPs promote the progeni-
tor-to-neuron transition by direct transcription of neu-
ron-specific genes. Finally, our studies examining glial
differentiation suggest that activated C/EBPs not only
promote neurogenesis, but also inhibit growth-factor-
mediated gliogenesis. Together, these data support a
model where growth factors that enhance the generation
of neurons do so via activation of a MEK-Rsk-C/EBP
signaling cascade that leads directly to transcription of
early, neuron-specific genes, while at the same time
Figure 6. Sites A, B, and C Are Essential for C/EBPs to trans-Acti- inhibiting the cells from responding to growth factors
vate the T1 -Tubulin Promoter that promote gliogenesis, such as CNTF.
(A) Gel shift assays with liver nuclear extracts and radiolabeled, Previous work has clearly demonstrated that intrinsic
double-stranded oligonucleotides corresponding to sites A, B, or genetic mechanisms play an essential role in regulating
C, and then competed with a 450-fold excess of either the wild- the generation of neurons from progenitor cells, but that
type or mutated (Amut, Bmut, and Cmut) oligonucleotides for the
these intrinsic programs are heavily influenced by envi-same sites.
ronmental determinants such as growth factors (Shen(B) Relative levels of activation of the wild-type versus mutant T1
-tubulin minimal promoter, as determined in NIH 3T3 cells by co- et al., 1998; Lillien, 1998). One example of such a growth
transfecting a fixed amount of the reporter CAT plasmids with in- factor is PDGF which, when added to cultured cortical
creasing amounts of the C/EBP expression plasmid. All data were progenitors, enhances neurogenesis in a transcription-
normalized to a cotransfected CMV:lacZ control plasmid. Relative dependent fashion, and inhibits CNTF-mediated glio-
activity indicates the relative level of acetylated chloramphenicol
genesis (Williams et al., 1997; Park et al., 1999). A secondproduced when the reporter plasmid was cotransfected with the
example is CNTF, which will prematurely induce theC/EBP-expressing plasmid versus cotransfection with the empty
expression vector. formation of astrocytes by cortical progenitor cells (Park
et al., 1999). In this regard, a key question is how these
growth factors signal to direct neural precursors to be-
come neurons versus glial cells. This question has beenfate (as occurs with CNTF treatment), or whether they
remained undifferentiated. To distinguish these two answered for CNTF- and BMP-mediated astrocyte for-
mation, which is at least partially due to activation ofpossibilities, at 3–4 days postplating, we performed dou-
ble-label analysis for flag, to detect A-C/EBP-expressing JAK-STAT (Bonni et al., 1997) and Smad-dependent (Na-
kashima et al., 1999) pathways, with synergistic interac-cells, and GFAP or nestin, markers for astrocytes and
neural progenitor cells, respectively. This analysis re- tions between the two pathways mediated via the tran-
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Figure 7. Inhibition of C/EBP Promotes Gliogenesis
(A) Immunocytochemistry for the flag tag in A-C/EBP and for the neural progenitor cell marker nestin showing that cells expressing aC/EBP
express nestin (arrows). Similar results were obtained in five separate experiments.
(B) Immunostaining of progenitors transduced with A-C/EBP (top three panels), -galactosidase (middle three panels), or GFP (bottom three
panels) adenoviruses, and treated with FGF2 plus CNTF for 5 days. The left panels are immunostaining for the appropriate viral protein, the
center for GFAP, and the right are Hoechst staining of the same fields. Arrows indicate the same cells in all three panels.
(C) Quantitation of data similar to that shown in (B), where progenitors were infected with A-C/EBP (Ad-aC/EBP), GFP (Ad-GFP), or
-galactosidase (Ad-B-gal) adenoviruses versus uninfected controls. Each group of bars derives from a different, independent experiment,
and results are mean 	 SE. *p  0.05; **p  0.005.
scriptional coactivators p300/CBP (Nakashima et al., quence of the repertoire of HLHs that they express, and
growth factor-mediated activation of the C/EBPs would1999). However, the signaling pathways utilized by fac-
tors such as PDGF to promote the generation of neurons provide the final “push” to trigger expression of a neu-
ronal phenotype via transcription of genes such as T1are largely unexplored. Thus, while a number of studies
indicate that bHLH transcription factors such as Mash1 -tubulin. Thus, expression of the appropriate bHLHs
would be a requisite for the neurogenic actions of theand Neurogenins1 and 2, as well as their negative regula-
tors, the Ids, are key intrinsic determinants of neurogen- C/EBPs; such necessary cooperativity would allow the
C/EBPs to function as growth factor-regulated differen-esis from cortical precursors (Sun et al., 2001; Nieto et
al., 2001; Toma et al., 2000), the work presented here tiation signals in a variety of different cell types. In this
sense, the C/EBPs would act neither as classic differen-identifies a novel, extrinsic, growth factor-mediated sig-
naling cascade that promotes the generation of neurons. tiation or fate signals, but would instead act, with regard
to their proneurogenic activities, as necessary cofactorsThe importance of this pathway in vivo during em-
bryogenesis is currently the subject of investigation. for fate-biasing molecules such as the bHLHs and, in
the case of their antigliogenic action, as negative modifi-Precedent for the C/EBP family of transcription fac-
tors acting to regulate cellular differentiation in response ers of cues such as CNTF that directly promote an
astrocytic fate.to growth factors derives from studies on a number of
developing systems, most notably hematopoiesis and How could the C/EBPs collaborate with the neuro-
genic bHLHs to generate a postmitotic neuron? Oneadipogenesis (Johnson and Williams, 1994; Lekstrom-
Hines and Xanthopoulos, 1998). In these systems, vari- potential link between these two families of transcription
factors are the transcriptional coactivators p300/CBPous members of the C/EBP family act in concert with
cell-type-specific determination signals to promote or (Goodman and Smolik, 2000). Interestingly, p300/CBP
bind to neurogenic bHLHs such as Neurogenin1 (Sunrepress transcription of genes essential for terminal dif-
ferentiation. By analogy, we propose that in cortical pro- et al., 2001) as well as to C/EBP (Mink et al., 1997). Thus,
p300/CBP may provide a key link between activatedgenitors, the C/EBPs act not as “determination” factors
in the same sense as bHLHs like the neurogenins, but C/EBPs and neurogenic bHLHs during neurogenesis.
Are the C/EBPs expressed at an appropriate time andas differentiation factors responsible for initiating the
transcription of early neuronal genes in response to place to cooperate with neurogenic bHLHs in such a
fashion? The RT-PCR data presented here indicate thatgrowth factor cues. In this model, progenitor cells would
be partially biased to become neurons as a conse- the mRNAs for C/EBPs , , and  are all expressed in
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cultured cortical progenitors, while the gel shift data regulated signaling cascade, a MEK-C/EBP pathway
confirms that functional C/EBPs, including C/EBP, are that promotes the genesis of neurons from neural pre-
expressed in cultured cortical progenitors, in the embry- cursors. We propose that this pathway provides an intra-
onic brain, and in cells from the embryonic telencepha- cellular mechanism for integrating and coupling diverse
lon from E12 to E18, likely both progenitors and neurons. growth factor stimuli to the intrinsic cellular machinery,
Since neurogenic bHLHs are expressed in cortical pro- thereby ensuring that neurons are generated in appro-
genitors both in vivo and in culture (Nieto et al., 2001; priate numbers at the appropriate time during develop-
F.B.H. and F.D.M., unpublished data), then such interac- ment.
tions may well occur.
Experimental ProceduresDo the C/EBPs also play a role in regulating terminal
mitosis as progenitors become neurons? Although our
Cortical Culturesdata do not directly address this issue, the C/EBPs have
Cortical progenitor cells were cultured from E12-E13 mouse em-
been implicated in growth arrest in nonneural cells, an bryos using protocols previously described (Slack et al., 1998; Glos-
effect they mediate at least partially via the pRb family ter et al., 1999; Toma et al., 2000). Cell density was 100,000 cells
(Chen et al., 1996), which is essential for cortical progeni- per well. For adenovirus infection, progenitor cells were infected at
the time of plating, and 24 hr later half the media was changed.tors to become neurons (Slack et al, 1996, 1998). More-
Cells were fed every 2 days. For experiments with PDGF or CNTF,over, interactions between pRb and C/EBP are thought
cells were plated first in FGF2 for 12 hr, and then PDGF or CNTFto enhance transcription of cell-type-specific genes dur-
plus FGF2 was added to the media for an additional 2.5 or 4.5 days.
ing differentiation of adipocytes (Chen et al., 1996). Thus,
interactions between the C/EBPs and the pRb family Recombinant Adenoviruses
could provide an integral link between terminal mitosis The recombinant adenoviruses expressing -galactosidase and
and induction of the neuronal phenotype in cortical pro- GFP are made in the Ad5 backbone and have been previously de-
scribed (Slack et al., 1996; Toma et al., 2000). The flag-tagged A-C/genitor cells.
EBP construct has been previously described (Krylov et al., 1997;Data presented here indicate that one-way growth
Greenwel et al., 2000) and was recombined into a replication-defi-factors activate the C/EBP family during neurogenesis
cient adenovirus backbone deleted in E1 and E3 (Ad-aC/EBP). Wild-
is via MEK-ERK-Rsk, a major, well-characterized kinase type or DN-MEK constructs (kindly provided by Natalie G. Ahn,
pathway downstream of tyrosine kinase receptors University of Colorado) were cloned into the replication-deficient
(Davis, 1995). In this regard, both FGF2 and PDGF acti- Ad5 backbone, which is deleted in E1 and E3 (U. Zirrgeibel et al.,
submitted). All adenoviruses drive expression from the CMV pro-vate C/EBPs in osteoblasts (Wadleigh and Herschman,
moter and were purified and titered as previously described (Slack1999), and a MEK-ERK-Rsk-C/EBP pathway has re-
et al., 1996; Toma et al., 2000).cently been implicated in the control of hepatocyte
proliferation in response to TGF (Buck et al., 1999).
Immunocytochemistry and TUNEL
However, while data presented here indicate that phos- Immunocytochemistry and TUNEL were performed essentially as
phorylation of C/EBP at the Rsk site is sufficient to described (Wartiovaara et al., 2002; Toma et al., 2000). The following
enhance neurogenesis, C/EBP can also be directly primary antibodies were used: polyclonal antibodies to -galactosi-
dase (ICN Biomedicals), NSE (Polysciences Inc.), nestin (Phar-phosphorylated by ERK itself (Nakajima et al., 1993;
mingen), neurofilament-M (Chemicon), GFAP (DAKO), and mono-Williams et al., 1995). Thus, tyrosine kinase receptors
clonal antibodies to the flag tag (Sigma), the HA-tag (Boehringer),may signal to activate the C/EBPs via several parallel
III-tubulin (RDI), NeuN (Chemicon), anti-phosphoERK (Promega),
signaling cascades, one of which is the MEK-ERK-Rsk or Ki67 (Pharmingen). All secondary antibodies were obtained from
pathway. Jackson Immunoresearch Laboratories Inc. (West Grove, PA).
One of the surprising findings reported here is that For quantitation, three to five random images of each treatment
activation of the C/EBPs not only promoted neurogen- (per experiment) were captured and processed. Digital image acqui-
sition and analysis was performed with the Northern Eclipse soft-esis, but also inhibited gliogenesis in response to CNTF.
ware (Empix Inc) using a Sony XC-75CE CCD video camera.Interestingly, previous work on PDGF during cortical
neurogenesis would predict such a result; PDGF en-
Western Blot Analysishanced the generation of neurons from cortical progeni-
For biochemistry, cortical progenitor cells were cultured in 60 cm
tors at the same time that it inhibited CNTF-mediated dishes, lysed, and analyzed as described previously (Toma et al.,
astrocyte formation (Park et al., 1999), effects that could 2000). Blots were probed with anti-flag, anti-HA, anti-phosphoERK,
both be explained by the MEK-Rsk- C/EBP pathway anti-phosphoRsk (Santa Cruz), and anti-Rsk (Santa Cruz).
defined here. Such a dual action may turn out to be the
RT-PCR Analysisrule rather than the exception, since recent work with
Total RNA from cortical progenitor cells was isolated with Triazolthe bHLHs indicate that they too bias progenitors to
as described by the manufacturer (GIBCO-BRL). cDNA was pre-become neurons at the same time that they inhibit them
pared from this RNA using random hexamer primers and M-MuLV
from becoming glial cells (Tomita et al., 2000; Nieto et al., reverse transcriptase as described by the manufacturer (MBI-Fer-
2001; Sun et al., 2001). For bHLHs such as Neurogenin1, mentas). The sequence of the primers used for the PCR reaction
these two effects are apparently mediated via different were: -actin, 5-TGGAGAAGAGCTATGAGCTGCCTG-3 and 5-GTGC
CACCAGACAGCACTGTGTTG-3; C/EBP, 5-GCGCGAGCGCAAmechanisms, with the proneurogenic effects being tran-
CAACATC-5 and 5-TGCTTGAACAAGTTCCGCAG-3; C/EBP, 5-scriptionally mediated and the antigliogenic effects re-
AAGGCCAAGAAGTCGGTGGA-3 and 5-CAGTTCACGGCTCAGCsulting from Neurogenin1-mediated sequestration of
TGTT-3; and C/EBP, 5-ACAGTCCGAGAAAAGGGCGC-3 and 5-p300/CBP (Sun et al., 2001). For the C/EBPs, it is clear
CCAGGTCCCGGGTGAGCT-3.
that at least some of the proneurogenic effects are tran-
scriptionally mediated, but the mechanisms underlying Transfection of Cortical Progenitor Cells
the antigliogenic effects remain to be determined. Cortical progenitor cells were plated at a density of 1  105 cells/
well of a 4-well chamber slide (Nalgene-Nunc) in 700 l of mediumTogether, these studies identify a novel growth factor-
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plus FGF2. A total of 1 g of DNA and 1 l of lipofectamine (GIBCO- tors, and the members of the Miller and Kaplan laboratories for
advice, discussions, and technical support. This work was sup-BRL) were added to 100 l of OPTI-MEM (GIBCO-BRL) medium,
which after mixing, was added to the plated cells overnight. The ported by grants from the Canadian Institutes of Health Research
to F.D.M. F.D.M. is a CIHR Senior Scientist and a Killam Scholar, andwild-type, dominant-negative, and Rsk-site phosphorylation mutant
C/EBPs were expressed in pCDNA3.1, containing the CMV pro- F.B.H. is supported by the CIHR, FRSQ, and a Tomlinson Foundation
Studentship. X.M.Y. was supported by a fellowship from the Cana-moter. GFP was expressed from pEGFP-N1 (Clontech). Wild-type
and DN-MEK were expressed from the CMV promoter in the same dian NeuroSciences Network during the course of this work.
Ad5-based plasmids used to generate the recombinant adenovirus.
Received: October 30, 2001
Revised: September 13, 2002Heterologous Cotransfection Assays
Plasmids used for the cotransfections included pMEX driving ex-
pression of C/EBP, , or  (Williams et al., 1991), pSV2CAT, and References
pUC19 containing the various T1 -tubulin promoter constructs
driving expression of CAT or -galactosidase. The -galactosidase Baer, M., and Johnson, P.F. (2000). Generation of truncated C/EBP
expression constructs were made by deleting a previously de- isoforms by in vitro proteolysis. J. Biol. Chem. 275, 26582–26590.
scribed T1:nlacZ transgene (Gloster et al., 1994) by excising se- Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D.A., Rozov-
quences upstream of176,110, or85 and leaving the remainder sky, I., Stahl, N., Yancopoulos, G.D., and Greenberg, M.E. (1997).
of the transgene. The point mutations in the T1 minimal promoter Regulation of gliogenesis in the central nervous system by the JAK-
were made using site-directed mutagenesis. All constructs were STAT signaling pathway. Science 278, 477–483.
confirmed by DNA sequencing. For cotransfections, cells were
Buck, M., Poli, V., van der Geer, P., Chojkier, M., and Hunter, T.grown to 60%–80% confluence and were transfected with 1–4 g
(1999). Phosphorylation of rat serine 105 or mouse threonine 217of the reporter plasmid, up to 4 g of plasmid expressing a C/EBP
on CEBP is required for hepatocyte proliferation induced by TGF.family member, and 1–4 g of pSV2CAT or CMV:-galactosidase
Mol. Cell 4, 1087–1092.plasmid for normalization. For saturation studies, varying amounts
Chen, P.-L., Riley, D.J., Chen, Y., and Lee, W.-H. (1996). Retinoblas-of the C/EBP expression plasmid were added, along with a carrier
toma protein positively regulates terminal adipocyte differentiationplasmid to ensure that the same amount of DNA was utilized at
through direct interaction with C/EBPs. Genes Dev. 10, 2794–2804.each point. Cells were transfected with Superfect (Qiagen) and har-
vested and lysed at 48 hr. -galactosidase activity was measured Davis, R.J. (1995). Transcriptional regulation by MAP kinase. Mol.
using ONPG (Promega) as per the manufacturer’s instructions. CAT Reprod. Dev. 42, 459–467.
assays were performed using BODIPY 1-deoxyCAM substrate (Stra- Ghosh, A., and Greenberg, M.E. (1995). Distinct roles for bFGF and
tagene) as per manufacturer’s instructions. NT-3 in the regulation of cortical neurogenesis. Neuron 15, 89–103.
Gloster, A., Wu, W., Speelman, A., Weiss, S., Causing, C., Pozniak,
Electrophoretic Mobility Shift Assays C., Reynolds, B., Chang, E., Toma, J.G., and Miller, F.D. (1994). The
The oligonucleotides used in the EMSAs are as follows (5 to 3, T1 -tubulin promoter specifies gene expression as a functional
sense strand): consensus C/EBP, TCGACTCCCTGATTGCGCAAT of neuronal growth and regeneration in transgenic mice. J. Neurosci.
AGGCTCC (Williams et al., 1995); site A, GAGAGATTACCTCATAC 14, 7319–7330.
CAT; mutant site A, GAGAGACCACCTCGTACCAT site B, GTCGCTT
Gloster, A., El-Bizri, H., Bamji, S.X., Rogers, D., and Miller, F.D.GCACCAATCACCA; mutant site B, GTCGCCCGCACCGATCACCA;
(1999). Early induction of T1 -tubulin transcription in neurons ofsite C, GGGGTCTGGACCAACAGGAAAAGG; oligonucleotide CMUT
the developing nervous system. J. Comp. Neurol. 405, 45–60.(site C with the putative C/EBP binding site mutated), GGGGT
Goodman, R.H., and Smolik, S. (2000). CBP/p300 in cell growth,CTGGAGGGGCAGGAAAAGG; and oligonucleotide C (site C mu-
transformation, and development. Genes Dev. 14, 1553–1577.tated outside of the putative C/EBP binding site) GGGGTCTGGAC
CAACAGCCCCAGG. In all cases, complementary oligonucleotides Greenwel, P., Tanaka, S., Penkov, D., Zhang, W., Olive, M., Moll, J.,
were also synthesized in the opposite orientation. 3 g of the two Vinson, C., Di Liberto, M., and Ramirez, F. (2000). Tumor necrosis
complementary oligonucleotides for each site were 5 end labeled factor alpha inhibits type I collagen synthesis through repressive
with 32P-ATP and T4 polynucleotide kinase (Promega), and the CCAAT/enhancer-binding proteins. Mol. Cell. Biol. 20, 912–918.
labeled oligonucleotides purified by gel filtration prior to annealing. Hieber, V., Dai, X., Foreman, M., and Goldman, D. (1998). Induction
Nuclear extracts were made as previously described (Husain et of alpha1-tubulin gene expression during development and regener-
al., 1996) with minor modifications. EMSAs were performed essen- ation of the fish central nervous system. J. Neurobiol. 37, 429–440.
tially as described (Lichtsteiner et al., 1987). 20–40 g of liver or
Husain, J., Lo, R., Grbavec, D., and Stifani, S. (1996). Affinity forbrain nuclear extract was incubated with 1.2 ng of annealed, 32P-
the nuclear compartment and expression during cell differentiationlabeled double-stranded oligonucleotide for 1 hr at 5C–8C in a 25
implicate phosphorylated Groucho/TLE1 forms of higher molecularl reaction volume containing 25 mM HEPES, 60 mM Kcl, 7.5%
mass in nuclear functions. Biochem. J. 317, 523–531.glycerol, 0.1 mM EDTA, 0.75 mM DTT, 5 mM MgCl2, pH 7.9, and 1
Johnson, P.F., and Williams, S.C. (1994). CCAAT/enhancer bindingg of poly-dIdC. Samples were analyzed on 5% acrylamide, 0.4 M
(C/EBP) proteins. In Liver Gene Expression, M. Yaniv and F. Tronche,glycine gels (pH 8.5) and analyzed with a phosphoimager. Competi-
eds. (Austin, TX: R.G. Landes), pp. 231–258.tion assays contained 150 or 200 ng of cold double-stranded oligo-
nucleotides. Supershifts were performed using one of two different Krylov, D., Kasai, K., Echlin, D.R., Taparowsky, E.J., Arnheiter, H.,
antibodies specific to C/EBP (Santa Cruz SC-150X, 8 g; Geneka, and Vinson, C. (1997). A general method to design dominant nega-
as per manufacturers instructions). For competitions and su- tives to B-HLHZip proteins that abolish DNA binding. Proc. Natl.
pershifts, the cold oligonucleotide or antibody were preincubated Acad. Sci. USA 94, 12274–12279.
with the nuclear extract at 5C–8C for 30 min prior to addition of Lasorella, A., Noseda, M., Beyna, M., Yokota, Y., and Iavarone, A.
labeled oligonucleotide. EMSAs were also performed using Gene- (2000). Id2 is a retinoblastoma protein target and mediates signalling
ka’s Nushift C/EBP supershift kit, with similar results. Gel shift via myc oncoproteins. Nature 407, 592–598.
assays with purified leucine-zipper transcription factors and A-C/
Lekstrom-Hines, J., and Xanthopoulos, K.B. (1998). Biological roleEBP were performed essentially as previously described (Moitra et
of the CCAAT/enhancer-binding protein family of transcription fac-al., 1998).
tors. J. Biol. Chem. 273, 28545–28548.
Lichtsteiner, S., Wuarin, J., and Schibler, U. (1987). The interplay ofAcknowledgments
DNA-binding proteins on the promoter of the mouse albumin gene.
Cell 51, 963–973.We would like to thank D. Kaplan and S. Stifani for discussions
and advice, K. Wartiovaara and F. Said for amplifying and purifying Lillien, L. (1998). Progenitor cells: what do they know and when do
they know it? Curr. Biol. 8, 872–874.adenoviruses, S. Morris for advice regarding transfection of progeni-
Neuron
610
Miller, F.D., Naus, C.C.G., Durand, M., Bloom, F.E., and Milner, R.J. (2002). N-myc promotes survival and induces S-phase entry of post-
mitotic sympathetic neurons. J. Neurosci. 22, 815–824.(1987). Isotypes of -tubulin are differentially regulated during neu-
ronal maturation. J. Cell Biol. 105, 3065–3073. Williams, S.C., Cantwell, C.A., and Johnson, P.F. (1991). A family of
C/EBP-related proteins capable of forming covalently liked leucineMink, S., Haenig, B., and Klempnauer, K.H. (1997). Interaction and
zipper dimers in vitro. Genes Dev. 5, 1553–1567.functional collaboration of p300 and C/EBP. Mol. Cell. Biol. 17,
6609–6617. Williams, S.C., Baer, M., Dillner, A.J., and Johnson, P.F. (1995). CRP2
(C/EBP) contains a bipartite regulatory domain that controls tran-Moitra, J., Mason, M.M., Olive, M., Krylov, D., Gavrilova, O., Marcus-
scriptional activation, DNA binding and cell specificity. EMBO J. 14,Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., et
3170–3183.al. (1998). Life without white fat: a transgenic mouse. Genes Dev.
12, 3168–3181. Williams, B.P., Park, J.K., Alberta, J.A., Muhlebach, S.G., Hwang,
G.Y., Roberts, T.M., and Stiles, C.D. (1997). A PDGF-regulated imme-Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M.,
diate early gene response initiates neuronal differentiation in ventric-Kishimoto, T., and Akira, S. (1993). Phosphorylation at threonine-
ular zone progenitor cells. Neuron 18, 553–562.235 by a ras-dependent mitogen-activated protein kinase cascade
is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci.
USA 90, 2207–2211.
Nakashima, K., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune,
T., Kawabata, M., Miyazono, K., and Taga, T. (1999). Synergistic
signaling in fetal brain by STAT3-Smad1 complex bridged by p300.
Science 284, 479–482.
Nieto, M., Schuurmans, C., Britz, O., and Guillemot, F. (2001). Neural
bHLH genes control the neuronal versus glial fate decision in cortical
progenitors. Neuron 29, 401–413.
Park, J.K., Williams, B.P., Alberta, J.A., and Stiles, C.D. (1999). Bipo-
tent cortical progenitor cells process conflicting cues for neurons
and glia in a hierarchical manner. J. Neurosci. 19, 10383–10389.
Qian, X., Shen, Q., Goderie, S.K., He, W., Capela, A., Davis, A.A.,
and Temple, S. (2000). Timing of CNS cell generation: a programmed
sequence of neuron and glial cell production from isolated murine
cortical stem cells. Neuron 28, 69–80.
Raballo, R., Rhee, J., Lyn-Cook, R., Leckman, J.F., Schwartz, M.L.,
and Vaccarino, F.M. (2000). Basic fibroblast growth factor (Fgf2) is
necessary for cell proliferation and neurogenesis in the developing
cerebral cortex. J. Neurosci. 20, 5012–5023.
Shen, Q., Qian, X., Capela, A., and Temple, S. (1998). Stem cells in
the embryonic cerebral cortex: their role in histogenesis and pat-
terning. J. Neurobiol. 36, 162–174.
Slack, R.S., Belliveau, D.J., Rosenberg, M., Atwal, J., Aloyz, R., Loch-
muller, H., Hagighi, A., Lach, B., Seth, P., Cooper, E., et al. (1996).
Adenovirus-mediated gene transfer of the tumor suppressor p53
induces apoptosis in postmitotic neurons. J. Cell Biol. 135, 1085–
1096.
Slack, R.S., El-Bizri, H., Wong, J., Belliveau, D.J., and Miller, F.D.
(1998). A critical temporal requirement for the retinoblastoma protein
family during neuronal determination. J. Cell Biol. 140, 1497–1509.
Sterneck, A., and Johnson, P.F. (1998). CCAAT/Enhancer binding
protein  is a neuronal transcriptional regulator activated by nerve
growth factor receptor signaling. J. Neurochem. 70, 2424–2433.
Sterneck, E., Paylor, R., Jackson-Lewis, V., Libbey, M., Przedborski,
S., Tessarollo, L., Crawley, J.N., and Johnson, P.F. (1998). Selectively
enhanced contextual fear conditioning in mice lacking the transcrip-
tional regulator CCAAT/enhancer binding protein . Proc. Natl. Acad.
Sci. USA 95, 10908–10913.
Sun, Y., Nadal-Vicens, M., Misono, S., Lin, M.Z., Zubiaga, A., Hua,
X., Fan, G., and Greenberg, M.E. (2001). Neurogenin promotes neu-
rogenesis and inhibits glial differentiation by independent mecha-
nisms. Cell 104, 365–376.
Toma, J.G., El-Bizri, H., Barnabe´-Heider, F., Aloyz, R., and Miller,
F.D. (2000). Evidence that helix-loop-helix proteins collaborate with
the retinoblastoma tumor suppressor protein to regulate cortical
neurogenesis. J. Neurosci. 20, 7648–7656.
Tomita, K., Moriyoshi, K., Nakanishi, S., Guillemot, F., and Kage-
yama, R. (2000). Mammalian achaete-scute and atonal homologs
regulate neuronal versus glial fate determination in the central ner-
vous system. EMBO J. 19, 5460–5472.
Wadleigh, D.J., and Herschman, H.R. (1999). Transcriptional regula-
tion of the cyclooxygenase-2 gene by diverse ligands in murine
osteoblasts. Biochem. Biophys. Res. Commun. 264, 865–870.
Wartiovaara, K., Barnabe-Heider, F., Miller, F.D., and Kaplan, D.R.
